Related Experiment Video
Updated: Jul 17, 2026
Chemical Modification of the Tryptophan Residue in a Recombinant Ca2+-ATPase N-domain for Studying Tryptophan-ANS FRET
Published on: October 9, 2021
Tryptophan-Mediated Sodium Dodecyl Sulfate Binding to Proteins
Taiji Oyama1, Teruo Akuta2, Tsutomu Arakawa3
1Sales Division, JASCO Corporation, 2967-5 Ishikawa, Hachioji, Tokyo, 192- 8537, Japan. taiji.oyama@jasco.co.jp.
Sodium dodecyl sulfate (SDS) binding to proteins like BSA, IgG, and lysozyme causes unfolding and alters local hydrophobic environments. This study reveals stoichiometric and cluster-like SDS binding modes influencing protein structure.
Area of Science:
- Biochemistry
- Protein Science
- Spectroscopy
Background:
- Sodium dodecyl sulfate (SDS) is a common detergent in protein research.
- Micellar binding is the established mechanism for SDS-protein interactions.
Purpose of the Study:
- To investigate the interaction mechanisms between SDS and proteins.
- To explore how SDS binding affects protein structure and local environments.
Main Methods:
- Near-UV circular dichroism (CD) spectroscopy
- Fluorescence spectroscopy
- SDS-gel electrophoresis
Main Results:
- SDS induced unfolding in Bovine Serum Albumin (BSA), IgG, and lysozyme without heating or reduction.
- Changes in local structures around tryptophan residues were observed with 0.05-1% SDS.
- SDS binding resulted in a blue shift of fluorescence emission, indicating increased hydrophobicity.
Conclusions:
- SDS binding to proteins involves both stoichiometric and cluster-like modes.
- These binding modes alter aromatic CD and fluorescence spectra by modifying local protein environments.
More Related Videos
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
09:31PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
Published on: September 26, 2020
Related Concept Videos
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
01:30Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
01:29Drug Distribution: Plasma Protein Binding
01:22Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
01:16Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...